
This study aimed to analyze the performance of magnetic resonance imaging (MRI) and prostate‐specific membrane antigen (PSMA)‐positron emission tomography (PET)/computed tomography (CT) for predicting pathologic non-organ confined disease (pT3) and lymph node involvement (pN+) in patients treated with SRP for radio recurrent PCa. In patients with recurrent radio PCa, MRI and 68Ga‐PSMA PET/CT are valuable tools for pre‐SRP staging and should be integrated into the standard workup. For lymph node metastases, 68Ga‐PSMA PET/CT is a solid rule-in test with nearly perfect specificity; in contrast, MRI had low accuracy for lymph node metastases.
Like
Save
Share